LiveseyG, TaylorR, LiveseyHF, et al.Dietary glycemic index and load and the risk of type 2 diabetes: a systematic review and updated meta-analyses of prospective cohort studies. Nutrients, 2019; 11: E1280.
2.
LiveseyG, LiveseyH. Coronary heart disease and dietary carbohydrate, glycemic index, and glycemic load: dose-response meta-analyses of prospective cohort studies. Mayo Clin Proc Innov Qual Outcomes, 2019; 3: 52–69.
3.
ChristensenP, Meinert LarsenT, Westerterp-PlantengaM, et al.Men and women respond differently to rapid weight loss: metabolic outcomes of a multi-centre intervention study after a low-energy diet in 2500 overweight, individuals with pre-diabetes (PREVIEW). Diabetes Obes Metab, 2018; 20: 2840–2851.
4.
AllerEEJG, LarsenTM, ClausH, et al.Weight loss maintenance in overweight subjects on ad libitum diets with high or low protein content and glycemic index: the DIOGENES trial 12-month results. Int J Obes, 2014; 38: 1511–1517.
5.
FogelholmM, LarsenTM, Westerterp-PlantengaM, et al.PREVIEW: Prevention of diabetes through lifestyle intervention and population studies in europe and around the world. design, methods, and baseline participant description of an adult cohort enrolled into a three-year randomised clinical trial. Nutrients. 2017; 9: E632.
6.
RabenA, VestentoftPS, Brand-MillerJ, et al.The PREVIEW intervention study: results from a 3-year randomized 2 x 2 factorial multinational trial investigating the role of protein, glycaemic index and physical activity for prevention of type 2 diabetes. Diabetes Obes Metab, 2021; 23: 324–337.
7.
AtkinsonFS, Foster-PowellK, Brand-MillerJC. International tables of glycemic index and glycemic load values: 2008. Diabetes Care, 2008; 31: 2281–2283.
8.
DimosthenopoulosC, LiatisS, KourpasE, et al.The beneficial short-term effects of a high-protein/low-carbohydrate diet on glycaemic control assessed by continuous glucose monitoring in patients with type 1 diabetes. Diabetes Obes Metab, 2021; 23: 1765–1774.
9.
ThomsenMN, SkytteMJ, SamkaniA, et al.Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial. Diabetologia, 2022; 65: 506–517.
10.
Gram-KampmannEM, HansenCD, HuggerMB, et al.Effects of a 6-month, low-carbohydrate diet on glycaemic control, body composition, and cardiovascular risk factors in patients with type 2 diabetes: an open-label randomized controlled trial. Diabetes Obes Metab, 2022; 24: 693–703.
11.
NichollsJ. Perspective: The glycemic index falls short as a carbohydrate food quality indicator to improve diet quality. Front Nutr, 2022; 9: 896333.
12.
GagnonC, LuZX, MaglianoDJ, et al.Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study). Diabetes Care, 2011; 34: 1133–1138.
13.
VillegasR, GaoYT, DaiQ, et al.Dietary calcium and magnesium intakes and the risk of type 2 diabetes: the Shanghai Women's Health Study. Am J Clin Nutr, 2009; 89: 1059–1067.
14.
ShahIU, SameenA, ManzoorMF, et al.Association of dietary calcium, magnesium, and vitamin D with type 2 diabetes among US adults: national health and nutrition examination survey 2007-2014-a cross-sectional study. Food Sci Nutr, 2021; 9: 1480–1490.
15.
MousaviSM, JalilpiranY, KarimiE, et al.Dietary intake of linoleic acid, its concentrations, and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of prospective cohort studies. Diabetes Care, 2021; 44: 2173–2181.
16.
ShahinfarH, JayediA, KhanTA, Shab-BidarS. Coffee consumption and cardiovascular diseases and mortality in patients with type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Nutr Metab Cardiovasc Dis, 2021; 31: 2526–2538.
17.
GaffneyK, LuceroA, Macartney-CoxsonD, et al.Effects of whey protein on skeletal muscle microvascular and mitochondrial plasticity following 10 weeks of exercise training in men with type 2 diabetes. Appl Physiol Nutr Metab, 2021; 46: 915–924.
18.
MohammadA, FalahiE, Mohd YusofBN, et al.The effects of the ginger supplements on inflammatory parameters in type 2 diabetes patients: a systematic review and meta-analysis of randomised controlled trials. Clin Nutr ESPEN, 2021; 46: 66–72.
19.
TajaddiniA, RoshanravanN, MobasseriM, et al.Saffron improves life and sleep quality, glycaemic status, lipid profile and liver function in diabetic patients: a double-blind, placebo-controlled, randomised clinical trial. Int J Clin Pract, 2021; 75: e14334.
20.
Hooshmand MoghadamB, RashidlamirA, Attarzadeh HosseiniSR, GaeiniAA, KavianiM. The effects of saffron (Crocus sativus L.) in conjunction with concurrent training on body composition, glycaemic status, and inflammatory markers in obese men with type 2 diabetes mellitus: a randomized double-blind clinical trial. Br J Clin Pharmacol, 2022; 88: 3256–3271.
21.
SangouniAA, OrangZ, Mozaffari-KhosraviH. Effect of omega-3 supplementation on fatty liver and visceral adiposity indices in diabetic patients with non-alcoholic fatty liver disease: a randomized controlled trial. Clin Nutr ESPEN, 2021; 44: 130–135.
22.
DelpinoFM, FigueiredoLM, da SilvaBGC, et al.Omega-3 supplementation and diabetes: a systematic review and meta-analysis. Crit Rev Food Sci Nutr, 2022; 62: 4435–4448.
23.
TaghizadehM, Mohammad ZadehA, Asemi ZFet al.Morus Alba leaf extract affects metabolic profiles, biomarkers inflammation and oxidative stress in patients with type 2 diabetes mellitus: a double-blind clinical trial. Clin Nutr ESPEN, 2022; 49: 68–73.
24.
BellingeJW, FrancisRJ, LeeSC, et al.The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr, 2022; 115: 45–52.
25.
VanweertF, NeinastM, TapiaEE, et al.A randomized placebo-controlled clinical trial for pharmacological activation of BCAA catabolism in patients with type 2 diabetes. Nat Commun, 2022; 13: 3508.
26.
ZhangX, ZhaoA, SandhuAK, EdirisingheI, Burton-FreemanBM. Red raspberry and fructo-oligosaccharide supplementation, metabolic biomarkers, and the gut microbiota in adults with prediabetes: a randomized crossover clinical trial. J Nutr, 2022; 152: 1438–1449.
27.
SasaniN, KazemiA, RezaiyanM, et al.Effect of artemisia extract on glycemic control: a systematic review and meta-analysis of randomized controlled trial. Int J Clin Pract, 2021; 75: e14719.
28.
BollandMJ, AvenellA, BaronJA, et al.Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ, 2010; 29;341: c3691.
29.
PittasAG, LauJ, HuFB, Dawson-HughesB. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab, 2007; 92: 2017–2029.
30.
WangX, ChenH, OuyangY, et al.Dietary calcium intake and mortality risk from cardiovascular disease and all causes: a meta-analysis of prospective cohort studies. BMC Med, 2014; 12: 158.
31.
RizzoliR, BiverE, Brennan-SperanzaTC. Nutritional intake and bone health. Lancet Diabetes Endocrinol, 2021; 9: 606–621.
32.
BellKJ, SmartCE, SteilGM, Brand-MillerJC, KingB, WolpertHA. Impact of fat, protein, and glycemic index on postprandial glucose control in type 1 diabetes: implications for intensive diabetes management in the continuous glucose monitoring era. Diabetes Care, 2015; 38: 1008–1015.
33.
BellKJ, ToschiE, SteilGM, WolpertHA. Optimized mealtime insulin dosing for fat and protein in type 1 diabetes: application of a model-based approach to derive insulin doses for open-loop diabetes management. Diabetes Care, 2016; 39: 1631–1634.
34.
ZaharievaDP, MesserLH, PaldusB, O'NealDN, MaahsDM, RiddellMC. Glucose control during physical activity and exercise using closed loop technology in adults and adolescents with type 1 diabetes. Can J Diabetes, 2020; 44: 740–749.
35.
HawJS, GalavizKI, StrausAN, et al.Long-term sustainability of diabetes prevention approaches: a systematic review and meta-analysis of randomized clinical trials. JAMA Intern Med, 2017; 177: 1808–1817.
36.
KnowlerWC, Barrett-ConnorE, FowlerSE, et al.Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med, 2002; 346: 393–403.
37.
RichterB, HemmingsenB, MetzendorfMI, TakwoingiY. Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia. Cochrane Database Syst Rev, 2018; 10: CD012661.
38.
SolomonTPJ. Sources of inter-individual variability in the therapeutic response of blood glucose control to exercise in type 2 diabetes: going beyond exercise dose. Front Physiol, 2018; 9: 896.
39.
TuomilehtoJ, LindströmJ, ErikssonJG, et al.Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med, 2001; 344: 1343–1350.
40.
MoserO, RiddellMC, EcksteinML, et al.Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA). Diabetologia, 2020; 63: 2501–2520.
41.
DovcK, PionaC, Yeşiltepe MutluG, et al.Faster compared with standard insulin aspart during day-and-night fully closed-loop insulin therapy in type 1 diabetes: a double-blind randomized crossover trial. Diabetes Care, 2020; 43: 29–36.
42.
LeeMH, PaldusB, VogrinS, et al.Fast-acting insulin aspart versus insulin aspart using a second-generation hybrid closed-loop system in adults with type 1 diabetes: a randomized, open-label, crossover trial. Diabetes Care, 2021; dc210814.
